Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Iterum Therapeutics plc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 45 | 41 | −4 |
| Shares | 6.56M | 5.10M | −1.46M (−22.3%) |
| Value | $2.57M | $1.80M | −$763.3K (−29.7%) |
New holders (4)
Institutions that held Iterum Therapeutics plc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 29,292 | $10.0K | 0.00% |
| Citigroup Inc | 1,300 | $0 | 0.00% |
| Northwestern Mutual Wealth Management Co | 388 | $0 | 0.00% |
| Captrust Financial Advisors | 500 | $0 | 0.00% |
Sold out (8)
Institutions that held Iterum Therapeutics plc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Anson Funds Management LP | 1,140,234 | $447.0K |
| Jane Street Group, LLC | 132,552 | $52.0K |
| Two Sigma Securities, LLC | 82,664 | $32.0K |
| XTX Topco Ltd | 38,654 | $15.0K |
| Tower Research Capital LLC (TRC) | 27,162 | $11.0K |
| Valeo Financial Advisors, LLC | 20,600 | $8.00K |
| Two Sigma Advisers, LP | 14,300 | $6.00K |
| Royal Bank of Canada | 3 | $0 |